NM_032119.4:c.1505C>A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_032119.4(ADGRV1):c.1505C>A(p.Ala502Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,613,436 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A502V) has been classified as Likely benign.
Frequency
Consequence
NM_032119.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADGRV1 | ENST00000405460.9 | c.1505C>A | p.Ala502Glu | missense_variant | Exon 8 of 90 | 1 | NM_032119.4 | ENSP00000384582.2 | ||
ADGRV1 | ENST00000504142.2 | n.271C>A | non_coding_transcript_exon_variant | Exon 2 of 14 | 5 | |||||
ADGRV1 | ENST00000640083.1 | n.1210C>A | non_coding_transcript_exon_variant | Exon 6 of 6 | 5 | |||||
ADGRV1 | ENST00000640109.1 | n.1601C>A | non_coding_transcript_exon_variant | Exon 8 of 9 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152180Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000287 AC: 42AN: 1461256Hom.: 0 Cov.: 31 AF XY: 0.0000220 AC XY: 16AN XY: 726868
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152180Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74342
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.1505C>A (p.A502E) alteration is located in exon 8 (coding exon 8) of the ADGRV1 gene. This alteration results from a C to A substitution at nucleotide position 1505, causing the alanine (A) at amino acid position 502 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at